Bleakley Financial Group’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,536
| Closed | -$35.7K | – | 1026 |
|
|
2024
Q4 | $35.7K | Sell |
10,536
-580
| -5% | -$1.97K | ﹤0.01% | 1030 |
|
|
2024
Q3 | $31.7K | Sell |
11,116
-1,040
| -9% | -$2.96K | ﹤0.01% | 1008 |
|
|
2024
Q2 | $27.4K | Buy |
+12,156
| New | +$27.4K | ﹤0.01% | 996 |
|
|
2023
Q4 | – | Sell |
-11,048
| Closed | -$20.5K | – | 979 |
|
|
2023
Q3 | $20.5K | Buy |
+11,048
| New | +$20.5K | ﹤0.01% | 873 |
|